BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8444656)

  • 1. Reactivity and protective capacity of a polyclonal antiserum derived from mice immunized with antibiotic exposed Escherichia coli.
    Raponi G; Lun MT; Lorino G; Nazzari C; Gaeta A; Mancini C; Filadoro F
    J Antimicrob Chemother; 1993 Jan; 31(1):117-28. PubMed ID: 8444656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Murine monoclonal antibody elicited with antibiotic-exposed Escherichia coli exerts protective capacity in experimental bacterial infections.
    Lun MT; Amatucci AM; Raponi G; Filadoro F; Bartolazzi A; Fraioli R; Natali PG; Mancini C
    J Med Microbiol; 1994 Sep; 41(3):179-83. PubMed ID: 8064837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunization of mice with antibiotic-treated Escherichia coli results in enhanced protection against challenge with homologous and heterologous bacteria.
    Raponi G; Keller N; Overbeek BP; Rozenberg-Arska M; Torensma R; Verhoef J
    J Infect Dis; 1991 Jan; 163(1):122-7. PubMed ID: 1701816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterisation and protective capacity of monoclonal antibodies elicited in mice against protein epitopes of antibiotic-exposed Escherichia coli.
    Lun MT; Raponi G; Amatucci AM; Natali PG; Fraioli R; Mancini C
    J Med Microbiol; 1997 Feb; 46(2):122-8. PubMed ID: 9060871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunization of mice with antibiotic treated Escherichia coli.
    Raponi G; Nazzari G; Lun MT; Lorino G; Valentini T; Bronzini M; Gaeta A; Mancini C; Filadoro F
    J Chemother; 1991 Jan; 3 Suppl 1():136-40. PubMed ID: 12041748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Balance of proinflammatory and antiinflammatory cytokines in mice immunized with Escherichia coli and correlation with mortality after lethal challenge.
    Raponi G; Ghezzi MC; Lun MT; Mancini C
    Med Microbiol Immunol; 1998 Jun; 187(1):11-6. PubMed ID: 9749978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human IgG but not IgM antibodies can protect mice from the challenge with live O6 Escherichia coli.
    Pontes GN; Massironi SG; Arslanian C; Palmeira P; Carneiro-Sampaio MM; Nagao AT
    Scand J Immunol; 2005 Oct; 62(4):353-60. PubMed ID: 16253122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective features of monoclonal antibodies to Escherichia coli during experimental infection of mice with homologous and heterologous serotypes of E. coli.
    Raponi G; Ghezzi MC; Lun MT; Bigotti G; Natali PG; Mancini C
    J Med Microbiol; 2000 Mar; 49(3):253-260. PubMed ID: 10707945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor necrosis factor alpha (TNF-alpha) production in mice immunized with Escherichia coli: correlation with mortality after lethal challenge and production of a native inhibitor of TNF-alpha activity.
    Raponi G; Keller N; Rozenberg-Arska M; Lun MT; Mancini C; Verhoef J
    Infect Immun; 1993 Sep; 61(9):3976-80. PubMed ID: 8359919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minimal concentration of human IgM and IgG antibodies necessary to protect mice from challenges with live O6 Escherichia coli.
    Massironi SM; Arslanian C; Carneiro-Sampaio MM; Pontes GN
    FEMS Immunol Med Microbiol; 2011 Nov; 63(2):193-201. PubMed ID: 22077222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of mucin and hemoglobin in experimental murine gram-negative bacteremia enhances the immunoprotective action of antibodies reactive with the lipopolysaccharide core region.
    Appelmelk BJ; Verwey-van Vught AM; Maaskant JJ; Schouten WF; Thijs LG; Maclaren DM
    Antonie Van Leeuwenhoek; 1986; 52(6):537-42. PubMed ID: 3545072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Passive protection against heterologous gram-negative bacteria mediated by antiserum to epimeraseless Rc mutant of Salmonella minnesota.
    Konstantinov G; Karacholeva M; Eskenazy M; Ivanova R; Vassileva J; Naumova F; Tekelieva R; Strahilov D
    Ann Immunol (Paris); 1982; 133D(1):71-6. PubMed ID: 6760795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective capacity of antibodies to outer-membrane components of Escherichia coli in a systemic mouse peritonitis model.
    Vuopio-Varkila J; Karvonen M; Saxén H
    J Med Microbiol; 1988 Feb; 25(2):77-84. PubMed ID: 2448461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiserum against Escherichia coli J5 contains antibodies reactive with outer membrane proteins of heterologous gram-negative bacteria.
    Hellman J; Zanzot EM; Loiselle PM; Amato SF; Black KM; Ge Y; Kurnick JT; Warren HS
    J Infect Dis; 1997 Nov; 176(5):1260-8. PubMed ID: 9359727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-reactive immunoprotective antibodies to Escherichia coli O111 rough mutant J5.
    Sakulramrung R; Domingue GJ
    J Infect Dis; 1985 Jun; 151(6):995-1004. PubMed ID: 3889175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Demonstration of cross-reactive antibodies to smooth gram-negative bacteria in antiserum to Escherichia coli J5.
    Baumgartner JD; O'Brien TX; Kirkland TN; Glauser MP; Ziegler EJ
    J Infect Dis; 1987 Jul; 156(1):136-43. PubMed ID: 2439613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effects of polyclonal sera and of monoclonal antibodies active to Salmonella minnesota Re595 lipopolysaccharide during experimental endotoxemia.
    Nys M; Cloes JM; Demonty J; Joassin L
    J Infect Dis; 1990 Nov; 162(5):1087-95. PubMed ID: 1700024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A noncovalent complex vaccine prepared with detoxified Escherichia coli J5 (Rc chemotype) lipopolysaccharide and Neisseria meningitidis Group B outer membrane protein produces protective antibodies against gram-negative bacteremia.
    Bhattacharjee AK; Opal SM; Taylor R; Naso R; Semenuk M; Zollinger WD; Moran EE; Young L; Hammack C; Sadoff JC; Cross AS
    J Infect Dis; 1996 May; 173(5):1157-63. PubMed ID: 8627067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody specific for Escherichia coli J5 cross-reacts to various degrees with an Escherichia coli clinical isolate grown for different lengths of time.
    McCallus DE; Norcross NL
    Infect Immun; 1987 May; 55(5):1042-6. PubMed ID: 3552983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Consequences of active or passive immunization of turkeys against Escherichia coli O78.
    Arp LH
    Avian Dis; 1980; 24(4):808-15. PubMed ID: 7023456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.